The Latest Cardiac and Vascular News
VANCOUVER, Jan. 2, 2018 /PRNewswire/ – Neovasc Inc. (NASDAQ, TSX:NVCN) announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on […]
The J.P. Morgan Healthcare Conference is held every year in early January, and this year it will be Jan. 8-11 in San Francisco, as usual. What isn’t quite as usual, and has some journalists and investors concerned, is a change in policy that limits media coverage. The meeting is a major event in […]
CHICAGO, Jan. 02, 2018 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr. Ravi Birla as its Chief Science Officer. Birla previously served as the Associate Director of the Department of Stem Cell Engineering […]
NEW YORK–(BUSINESS WIRE)– PAVmed (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that it intends to temporarily reduce the exercise price of the Company’s outstanding Series W Warrants (Nasdaq: PAVMW, the “Warrants”) to $2.50 per share. The Company intends to file tender offer materials (the “Offer”) […]
FRANKLIN LAKES, N.J., Dec. 22, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today’s clearance by the U.S. Federal Trade Commission (FTC) for BD to acquire C. R. Bard (NYSE: BCR), contingent on the divestitures of BD’s soft tissue core […]
MARLBOROUGH, Mass., Dec. 21, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 4, 2018 in Boston, MA. Mike Mahoney, chairman and chief executive officer, will participate in a 30-minute question-and-answer session with the host analyst beginning at approximately 9:30 a.m. A live webcast […]
REDWOOD CITY, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the Lumivascular approach to treating vascular disease, announced today it has entered into an agreement with CRG to waive […]
ABBOTT PARK, Ill., Dec. 15, 2017 /PRNewswire/ — The board of directors of Abbott (NYSE: ABT) today increased the company’s quarterly common dividend to 28 cents per share from 26.5 cents per share. This marks the 376th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Feb. 15, 2018, to shareholders of record at […]
SAN FRANCISCO–(BUSINESS WIRE)– Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced it completed $5.5 million in financing. The Series A round was led by existing investor Khosla Ventureswith participation from new investors including Data Collective (DCVC), Greenbox Venture Partners, Minneapolis Heart Institute Ventures and Georges Harik. […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow today announced that Health Care Service Corporation (HCSC), which operates Blue Cross and Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and Texas, has issued a medical policy for the HeartFlow® FFRct Analysis, a first-of-its-kind non-invasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). HCSC […]
